The improvement of tuberculosis diagnosis and treatment regimens depends on the identification of suitable biomarkers. Analysis of host immunological markers at diagnosis and throughout treatment may aid new drug development and the clinical management of individual patients.
- Gerhard Walzl
- Katharina Ronacher
- Alimuddin Zumla